Eculizumab (By injection)
e-kue-LIZ-oo-mab
Treats paroxysmal nocturnal hemoglobinuria (PNH) and atypical hemolytic uremic syndrome (aHUS).
Drug classes
Blood Modifier Agent (About this – PubMed Health)
Uses
Uses of This Medicine
Eculizumab injection is a monoclonal antibody. It is used to treat a type of blood disease called paroxysmal nocturnal hemoglobinuria (PNH). This medicine helps reduce red blood cell destruction or breakdown (hemolysis) in patients with PNH.
This medicine is also used to treat a serious kidney disorder called atypical hemolytic uremic syndrome (aHUS).
This medicine is available only under a restricted distribution program called Soliris® REMS (Risk Evaluation and Mitigation Strategy) Program.
Other uses (PubMed Health)
How To Use
Injectable
Your doctor will prescribe your dose and schedule. This medicine is given through a needle placed in a vein.
A nurse or other health provider will give you this medicine.
This medicine should come with a Medication Guide. Ask your pharmacist for a copy if you do not have one.
Missed dose: Call your doctor or pharmacist for instructions.
Drugs and Foods to Avoid
Ask your doctor or pharmacist before using any other medicine, including over-the-counter medicines, vitamins, and herbal products.
When Not To Use
This medicine is not right for everyone. You should not receive it if you had an allergic reaction to eculizumab.
Warnings
Tell your doctor if you are pregnant or breastfeeding, or if you have any kind of infection.
This medicine can increase your risk of serious infections, including meningococcal infection. You will need to be vaccinated against meningococcal infection at least 2 weeks before you start treatment with this medicine. You will also be given a patient safety card that lists the symptoms of infection and what to do if you have them. Carry the card with you at all times. Show the card to any doctor who treats you.
This medicine can also cause an infusion reaction that can be life-threatening.
For patients with PNH: When you stop receiving this medicine, you could develop hemolysis (breakdown of red blood cells). Your doctor will monitor you for at least 8 weeks.
For patients with aHUS: When you stop receiving this medicine, you could develop a type of blood clot called thrombotic microangiopathy. Your doctor will monitor you for at least 12 weeks to watch for this.
Your doctor will do lab tests at regular visits to check on the effects of this medicine. Keep all appointments.
Possible side effects
Summary More details
Call your doctor right away if you notice any of these side effects:
Allergic reaction: Itching or hives, swelling in your face or hands, swelling or tingling in your mouth or throat, chest tightness, trouble breathing
Confusion, sensitivity to light, headache with nausea and vomiting, stiff neck, fever, or rash
Fast or uneven heartbeat
Fever, chills, cough, sore throat, body aches
Unusual tiredness or weakness
If you notice these less serious side effects, talk with your doctor:
Diarrhea, nausea, vomiting
Pain, itching, burning, swelling, or a lump under your skin where the needle is placed
Runny or stuffy nose
If you notice other side effects that you think are caused by this medicine, tell your doctor.
Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
More side effects of this drug
Brand names include
Soliris
There may be other brand names for this medicine.